Evicenter
P&T meetings

Imlifidase

Kidney transplantation in highly sensitized patients

Manufacturer
Hansa Biopharma
Regulatory submission
BLA submitted December 2025
Last updated
85 sources

Product information and disease descriptionProduct descriptionProduct informationDosing and administration

Administration

2 evidence topics · 2 sources

Route and infusion duration

“intravenous use only” (opens the source at this quote in a new tab)

“15 minutes” (opens the source at this quote in a new tab)

Premedication

“Pre-medication: IV chlorpheniramine 10mg and IV hydrocortisone 200mg to prevent infusion reactions.” (opens the source at this quote in a new tab)